We're Not Very Worried About Veritas In Silico's (TSE:130A) Cash Burn Rate
Apr 14
Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis
UpdatedMay 02, 2026
DataAggregated Company Financials
Companies14
- 7D-1.9%
- 3M-9.0%
- 1Y-6.2%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.9%, driven by a pullback from Shin Nippon Biomedical Laboratories of 1.9%. The industry has fallen 6.2% in the last year. Looking forward, earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 03 May 2026 | JP¥137.3b | JP¥63.3b | -JP¥864,496,000.00 | 22.1x | -158.9x | 2.2x |
| Tue, 31 Mar 2026 | JP¥136.9b | JP¥63.3b | -JP¥864,966,000.00 | 20.8x | -158.2x | 2.2x |
| Thu, 26 Feb 2026 | JP¥152.6b | JP¥63.2b | -JP¥944,048,000.00 | 25.2x | -161.6x | 2.4x |
| Sat, 24 Jan 2026 | JP¥153.3b | JP¥66.9b | JP¥72.2m | 23.4x | 2124x | 2.3x |
| Mon, 22 Dec 2025 | JP¥155.9b | JP¥66.9b | JP¥72.2m | 20.2x | 2159.1x | 2.3x |
| Wed, 19 Nov 2025 | JP¥141.2b | JP¥67.3b | JP¥434.9m | 17.4x | 324.6x | 2.1x |
| Fri, 17 Oct 2025 | JP¥140.3b | JP¥66.5b | JP¥1.5b | 16.3x | 96.2x | 2.1x |
| Sun, 14 Sep 2025 | JP¥146.1b | JP¥66.5b | JP¥1.5b | 16.6x | 100.2x | 2.2x |
| Tue, 12 Aug 2025 | JP¥141.3b | JP¥66.7b | JP¥1.2b | 18x | 118.6x | 2.1x |
| Thu, 10 Jul 2025 | JP¥142.2b | JP¥66.0b | JP¥1.1b | 16.2x | 125.9x | 2.2x |
| Sat, 07 Jun 2025 | JP¥135.2b | JP¥66.0b | JP¥1.1b | 16.8x | 119.3x | 2x |
| Mon, 05 May 2025 | JP¥143.7b | JP¥64.2b | JP¥1.5b | 14.8x | 93.5x | 2.2x |
| Wed, 02 Apr 2025 | JP¥152.7b | JP¥64.8b | JP¥927.4m | 14.7x | 164.6x | 2.4x |
| Fri, 28 Feb 2025 | JP¥163.3b | JP¥65.1b | JP¥1.1b | 15.6x | 146.3x | 2.5x |
| Sun, 26 Jan 2025 | JP¥162.7b | JP¥62.0b | JP¥440.7m | 17.7x | 369.2x | 2.6x |
| Tue, 24 Dec 2024 | JP¥161.1b | JP¥62.0b | JP¥440.7m | 17.9x | 365.6x | 2.6x |
| Thu, 21 Nov 2024 | JP¥154.6b | JP¥62.6b | JP¥1.2b | 19.9x | 125x | 2.5x |
| Sat, 19 Oct 2024 | JP¥155.0b | JP¥61.5b | JP¥1.8b | 22.6x | 84.2x | 2.5x |
| Mon, 16 Sep 2024 | JP¥154.3b | JP¥61.5b | JP¥1.8b | 18.3x | 83.8x | 2.5x |
| Wed, 14 Aug 2024 | JP¥146.8b | JP¥61.7b | JP¥2.1b | 18.5x | 69.9x | 2.4x |
| Fri, 12 Jul 2024 | JP¥163.1b | JP¥61.8b | JP¥3.2b | 25.8x | 50.4x | 2.6x |
| Sun, 09 Jun 2024 | JP¥161.7b | JP¥61.8b | JP¥3.3b | 25x | 49.4x | 2.6x |
| Tue, 07 May 2024 | JP¥182.7b | JP¥62.3b | JP¥3.3b | 14x | 55.5x | 2.9x |
| Thu, 04 Apr 2024 | JP¥180.5b | JP¥62.3b | JP¥3.3b | 14.2x | 54.8x | 2.9x |
| Sat, 02 Mar 2024 | JP¥240.5b | JP¥155.3b | JP¥8.7b | 14.1x | 27.7x | 1.5x |
| Mon, 29 Jan 2024 | JP¥226.8b | JP¥167.1b | JP¥8.5b | 15.3x | 26.7x | 1.4x |
| Wed, 27 Dec 2023 | JP¥218.6b | JP¥167.1b | JP¥8.5b | 14.6x | 25.7x | 1.3x |
| Fri, 24 Nov 2023 | JP¥234.9b | JP¥167.4b | JP¥8.7b | 15x | 27x | 1.4x |
| Sun, 22 Oct 2023 | JP¥228.1b | JP¥179.3b | JP¥12.8b | 14.1x | 17.9x | 1.3x |
| Tue, 19 Sep 2023 | JP¥254.7b | JP¥179.3b | JP¥12.8b | 15.5x | 19.9x | 1.4x |
| Thu, 17 Aug 2023 | JP¥263.8b | JP¥179.2b | JP¥12.7b | 16.1x | 20.7x | 1.5x |
| Sat, 15 Jul 2023 | JP¥270.1b | JP¥178.5b | JP¥16.2b | 16.6x | 16.6x | 1.5x |
| Mon, 12 Jun 2023 | JP¥281.8b | JP¥178.3b | JP¥16.2b | 16.8x | 17.4x | 1.6x |
| Wed, 10 May 2023 | JP¥289.1b | JP¥178.9b | JP¥16.3b | 16.4x | 17.7x | 1.6x |
Price to Earnings Ratio
17.7x
Current Industry PE
- Investors are relatively neutral on the Japanese Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 29% per year, which is driving profits down.
Industry Comparison
How does Japanese Clinical Research and Equipment compare with similar industries?
| JP Market | 0.29% | |
| Healthcare | -2.55% | |
| Life Sciences | -1.87% | |
| Clinical Research and Equipment | -1.87% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4241 atect | JP¥757.00 | 2.3% +JP¥75.2m | 101.9% | PE25.4x | |
| 4583 Chiome Bioscience | JP¥101.00 | 1.0% +JP¥70.9m | -24.6% | PS12.1x | |
| 130A Veritas In Silico | JP¥470.00 | 1.3% +JP¥38.9m | -30.2% | PS33.5x | |
| 7079 WDB coco | JP¥2.62k | 0.3% +JP¥21.6m | -23.5% | PE8.9x |